Rob Glassman, M.D.
Dr. Glassman served as a senior investment banker for 17 years at Merrill Lynch, as well as Vice Chairman at Credit Suisse since 2015. Since then, he has returned to OrbiMed Advisors as the only venture partner in public equity; he had been a private equity partner 2009-10. Earlier in his career, Dr. Glassman was part of the Merrill Lynch Global Private Equity group, where he oversaw a very successful healthcare portfolio. He also consulted for a wide range of clients within McKinsey & Company’s Pharmaceutical and Medical Products practice. Dr. Glassman is also a board-certified hematologist-oncologist and holds a faculty appointment at Weill Cornell as a Clinical Assistant Professor of Medicine. Dr. Glassman received his AB magna cum laude from Harvard College and an MD from Harvard Medical School. He also spent several years as a basic science investigator at Rockefeller University in the laboratory of Hidesaburo Hanafusa, where he received Howard Hughes Medical Institute and American Cancer Society awards.